Is Burkina Faso ready to introduce new maternal vaccines against respiratory syncytial virus (RSV) and group B streptococcus (GBS)?
Dr Serge Ouoba of the Clinical Research Unit of Nanoro (CRUN) shares what a nationwide readiness assessment found.
Working with the Maternal Immunisation Readiness Network in Africa and Asia (MIRNA), researchers examined Burkina Faso’s health system across human resources, cold chain, financing, and policy and governance.
They also ran systematic reviews on disease burden, costing analyses with the EPI department, and community assessments on how pregnant women view the vaccines.
